Biopharmaceuticals
Cardiology
FDA
News Release - May 28, 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Source: The Medicines Company
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.